NUWACELL Trademark
Trademark Overview
On Friday, July 4, 2025, a trademark application was filed for NUWACELL with the United States Patent and Trademark Office. The USPTO has given the NUWACELL trademark a serial number of 79435869. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Friday, May 22, 2026. This trademark is owned by Nuwacell Biotechnologies Co., Ltd.. The NUWACELL trademark is filed in the Pharmaceutical Products category with the following description:
Chemical preparations for medical purposes, namely, cell therapy, anti-inflammatory and tissue repair, regenerative medicine, and immunotherapy; biological preparations for medical purposes, namely, cell therapy, anti-inflammatory and tissue repair, regenerative medicine and immunotherapy; biological tissue cultures for medical purposes; chemical reagents for medical or veterinary purposes; pharmaceutical preparations for medical purposes, namely, cell therapy, anti-inflammatory and tissue repair, regenerative medicine and immunotherapy; diagnostic preparations for medical purposes; organotherapy preparations; dietetic food substances adapted for medical use; medical dressings.
General Information
| Serial Number | 79435869 |
| Word Mark | NUWACELL |
| Filing Date | Friday, July 4, 2025 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Friday, May 22, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Chemical preparations for medical purposes, namely, cell therapy, anti-inflammatory and tissue repair, regenerative medicine, and immunotherapy; biological preparations for medical purposes, namely, cell therapy, anti-inflammatory and tissue repair, regenerative medicine and immunotherapy; biological tissue cultures for medical purposes; chemical reagents for medical or veterinary purposes; pharmaceutical preparations for medical purposes, namely, cell therapy, anti-inflammatory and tissue repair, regenerative medicine and immunotherapy; diagnostic preparations for medical purposes; organotherapy preparations; dietetic food substances adapted for medical use; medical dressings. |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 30, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Nuwacell Biotechnologies Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | CN |
Trademark Events
| Event Date | Event Description |
| Thursday, October 30, 2025 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Monday, November 3, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, November 3, 2025 | APPLICATION FILING RECEIPT MAILED |
| Friday, November 21, 2025 | ASSIGNED TO EXAMINER |
| Wednesday, December 3, 2025 | NON-FINAL ACTION WRITTEN |
| Thursday, December 4, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Friday, February 6, 2026 | REFUSAL PROCESSED BY MPU |
| Friday, February 6, 2026 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Thursday, February 26, 2026 | REFUSAL PROCESSED BY IB |
| Friday, May 22, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, May 22, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, May 22, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
